General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice, 42713-42714 [2011-18064]

Download as PDF Federal Register / Vol. 76, No. 138 / Tuesday, July 19, 2011 / Notices meeting and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Jennifer Brooks at least seven days in advance of the meeting. Information about the Committee and this meeting can be found at the Committee Web site, https://www.acf.hhs.gov/programs/opre/ hs/advisory_com/. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: June 29, 2011. George H. Sheldon, Acting Assistant Secretary for Children and Families. [FR Doc. 2011–18098 Filed 7–18–11; 8:45 am] BILLING CODE 4184–22–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Notice of Meeting; Administration for Native Americans Administration for Children and Families, Department of Health and Human Services. ACTION: Notice of Tribal Consultation. sroberts on DSK5SPTVN1PROD with NOTICES AGENCY: SUMMARY: The Department of Health and Human Services (HHS), Administration for Children and Families (ACF) will host a tribal consultation to solicit input on the agency’s programs. DATES: August 18, 2011. ADDRESSES: Room 800, 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Lillian A. Sparks, Commissioner, Administration for Native Americans, at 202–401–5590, by e-mail at Lillian.sparks@acf.hhs.gov or by mail at 370 L’Enfant Promenade, SW., 2 West, Washington, DC 20447. SUPPLEMENTARY INFORMATION: On September 29, 2010, ACF held its first Tribal Consultation Session in 5 years. The purpose of that session was to receive input to ACF’s draft Tribal Consultation Policy and ACF has been working hard to finalize that policy. ACF Principals will once again be available to speak with tribal leaders to discuss issues important to the tribes. This year’s session will focus on ACF tribal program priorities and will include a listening session on tribal selfgovernance. Testimonies may be submitted no later than August 5, 2011, to: Lillian Sparks, Commissioner, VerDate Mar<15>2010 17:20 Jul 18, 2011 Jkt 223001 42713 Administration for Native Americans, 370 L’Enfant Promenade, SW., Washington, DC 20447, anacommissioner@acf.hhs.gov. In addition to the Tribal Consultation Session, ACF will be hosting a Tribal Training and Technical Assistance Day to provide information about ACF programs, the grants process and financial management, technical assistance available from ACF, and ACF’s Interoperability Innovation Initiative. The Tribal Training and Technical Assistance Day will take place on August 17, 2011, at the same address as the Tribal Consultation Session, listed above. ACF is encouraging tribes to send their tribal planning officers or comparable employee to attend the Tribal Training and Technical Assistance Day. Registration for both the Tribal Training and Technical Assistance Day and the Tribal Consultation Session can be made at the following Web site address: https:// www.acfconsultation.com/. The Office of Child Support Enforcement (OCSE) also will be extending an invitation to tribal leaders to engage in an additional day of consultation and dialogue concerning tribal child support issues. This consultation will take place on August 19, 2011, the day after the ACF Tribal Consultation Session. It will be held in the multipurpose room on the 7th Floor of the Aerospace Building, located at 901 D Street, SW., Washington, DC 20447. Additional information will be sent out by OCSE under separate cover. SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Friday, July 8, 2011 (76 FR 40374). The document announced that a proposed collection information had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The document was published with an incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993–0002, 301– 796–9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2011–17141, appearing on page 40374 in the Federal Register of Friday, July 8, 2011, the following correction is made: 1. On page 40374, in the first column, in the heading of the document, ‘‘[Docket No. FDA–2011–N–0237]’’ is corrected to read ‘‘[Docket No. FDA– 2008–N–0341]’’. Dated: July 11, 2011. George H. Sheldon, Acting Assistant Secretary for Children and Families. [Docket No. FDA–2011–N–0478] [FR Doc. 2011–18096 Filed 7–18–11; 8:45 am] Dated: July 14, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–18143 Filed 7–18–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice AGENCY: BILLING CODE 4184–34–P Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2008–N–0341] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Applications for Food and Drug Administration Approval To Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs; Correction AGENCY: Food and Drug Administration, HHS. ACTION: PO 00000 Notice; correction. Frm 00040 Fmt 4703 Sfmt 4703 ACTION: Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee. This meeting was announced in the Federal Register of July 7, 2011 (76 FR 39882). The amendment is being made to reflect a change in the Contact Person portion of the document. There are no other changes. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993–0002, 301–796–6313, or FDA Advisory Committee Information Line, E:\FR\FM\19JYN1.SGM 19JYN1 42714 Federal Register / Vol. 76, No. 138 / Tuesday, July 19, 2011 / Notices 1–800–741–8138 (301–443–0572 in the Washington DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. SUPPLEMENTARY INFORMATION: In the Federal Register of July 7, 2011, FDA announced that a meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee would be held on August 30 and 31, 2011. On page 39883, in the first column, the Contact Person portion of the document is changed to read as follows: Contact Person: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993–0002, 301–796–6313, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees. Dated: July 13, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–18064 Filed 7–18–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0002] Science Board Advisory Committee; Notice of Meeting sroberts on DSK5SPTVN1PROD with NOTICES AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. VerDate Mar<15>2010 17:20 Jul 18, 2011 Jkt 223001 Name of Committee: Science Board to the Food and Drug Administration (Science Board). General Function of the Committee: The Science Board provides advice primarily to the Commissioner of Food and Drugs and other appropriate officials on specific complex and technical issues, as well as emerging issues within the scientific community in industry and academia. Additionally, the Science Board provides advice to the Agency on keeping pace with technical and scientific evolutions in the fields of regulatory science, on formulating an appropriate research agenda, and on upgrading its scientific and research facilities to keep pace with these changes. It will also provide the means for critical review of Agencysponsored intramural and extramural scientific research programs. Date and Time: The meeting will be held on Friday, August 19, 2011, from 9 a.m. to 3 p.m. Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (rm. 1503), Silver Spring, MD 20993– 0002. For those unable to attend in person, the meeting will also be Web cast. The link for the Web cast is available at https:// collaboration.fda.gov/scienceboard/. Information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at: https://www.fda.gov/ AdvisoryCommittees/default.htm; under the heading ‘‘Resources for You,’’ click on ‘‘Public Meetings at the FDA White Oak Campus.’’ Please note that visitors to the White Oak Campus must enter through Building 1. Contact Person: Martha Monser, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 4286, Silver Spring, MD 20993–0002, 301–796–4627, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), and follow the prompts to the desired center or product area. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. Agenda: On August 19, 2011, the Science Board will discuss the FDA’s PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 draft Strategic Plan for Regulatory Science. The Board will be provided with an update on the FDA’s Medical Countermeasures Initiative program plans. The Board will also initiate the charges to the subcommittees for: (1) A science review of the Center for Devices and Radiological Health, and (2) a Medical and Biological Engineering review. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ AdvisoryCommittees/Calendar/ default.htm. Scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before Friday, August 12, 2011. Oral presentations from the public will be scheduled between approximately 1 and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before Thursday, August 4, 2011. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by Friday, August 5, 2011. Persons attending FDA’s advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Martha Monser, at least 7 days in advance of the meeting. E:\FR\FM\19JYN1.SGM 19JYN1

Agencies

[Federal Register Volume 76, Number 138 (Tuesday, July 19, 2011)]
[Notices]
[Pages 42713-42714]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18064]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0478]


General and Plastic Surgery Devices Panel of the Medical Devices 
Advisory Committee; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the General and Plastic Surgery Devices 
Panel of the Medical Devices Advisory Committee. This meeting was 
announced in the Federal Register of July 7, 2011 (76 FR 39882). The 
amendment is being made to reflect a change in the Contact Person 
portion of the document. There are no other changes.

FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993-0002, 301-796-6313, 
or FDA Advisory Committee Information Line,

[[Page 42714]]

1-800-741-8138 (301-443-0572 in the Washington DC area), and follow the 
prompts to the desired center or product area. Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of July 7, 2011, FDA 
announced that a meeting of the General and Plastic Surgery Devices 
Panel of the Medical Devices Advisory Committee would be held on August 
30 and 31, 2011. On page 39883, in the first column, the Contact Person 
portion of the document is changed to read as follows:
    Contact Person: James Swink, Center for Devices and Radiological 
Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
66, rm. 1609, Silver Spring, MD 20993-0002, 301-796-6313, or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington, DC area), and follow the prompts to the desired center 
or product area. Please call the Information Line for up-to-date 
information on this meeting. A notice in the Federal Register about 
last minute modifications that impact a previously announced advisory 
committee meeting cannot always be published quickly enough to provide 
timely notice. Therefore, you should always check the Agency's Web site 
and call the appropriate advisory committee hot line/phone line to 
learn about possible modifications before coming to the meeting.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: July 13, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-18064 Filed 7-18-11; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.